These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6624782)

  • 21. Mesangial immunoglobulin A deposits in minimal change nephrotic syndrome: a report of an older patient and review of the literature.
    Clive DM; Galvanek EG; Silva FG
    Am J Nephrol; 1990; 10(1):31-6. PubMed ID: 2111636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recovery of minimal change nephrotic syndrome and acute renal failure in a patient withRenal cell carcinoma.
    Auguet T; Lorenzo A; Colomer E; Zamora A; García C; Martínez-Vea A; Richart C; Oliver JA
    Am J Nephrol; 1998; 18(5):433-5. PubMed ID: 9730570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease?
    Westhoff TH; Waldherr R; Loddenkemper C; Ries W; Zidek W; van der Giet M
    Clin Nephrol; 2006 Mar; 65(3):203-7. PubMed ID: 16550751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
    Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal change disease as the etiology of the nephrotic syndrome in a patient with angioimmunoblastic lymphadenopathy.
    Staszewski H; Kumar G; Mishriki Y
    Med Pediatr Oncol; 1988; 16(3):206-9. PubMed ID: 3380062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of Guillain-Barré syndrome developed minimal change nephrotic syndrome simultaneously.
    Kitamura H; Nakano T; Kakihara M; Nishino M; Isshiki K; Kawano K; Yamauchi A; Imai E; Kamada T; Abe H
    Am J Nephrol; 1998; 18(2):151-4. PubMed ID: 9569959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal change nephrotic syndrome developing during postoperative interferon-beta therapy for malignant melanoma.
    Nakao K; Sugiyama H; Makino E; Matsuura H; Ohmoto A; Sugimoto T; Ichikawa H; Wada J; Yamasaki Y; Makino H
    Nephron; 2002 Apr; 90(4):498-500. PubMed ID: 11961411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coexistence of atheroemboli and minimal-change disease.
    Liss KA; Gaughan WJ; McCue PA; Burke JF
    Clin Nephrol; 1997 Feb; 47(2):125-8. PubMed ID: 9049462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal renal amyloidosis with nephrotic syndrome.
    Jones BA; Shapiro HS; Rosenberg BF; Bernstein J
    Arch Pathol Lab Med; 1986 Oct; 110(10):889-92. PubMed ID: 3533001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thin basement membrane nephropathy associated with minimal change disease in a 15-year-old boy.
    Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takemoto M; Takada M; Shimizu T; Yamashiro Y
    Pediatr Nephrol; 2006 Feb; 21(2):277-80. PubMed ID: 16362391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute renal failure of short duration in minimal lesion nephrotic syndrome of childhood.
    Steele BT; Bacheyie GS; Baumal R; Rance CP
    Int J Pediatr Nephrol; 1982 Jun; 3(2):59-62. PubMed ID: 7107120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible acute renal failure in idiopathic nephrotic syndrome.
    Furuya R; Kumagai H; Ikegaya N; Kobayashi S; Kimura M; Hishida A; Kaneko E
    Intern Med; 1993 Jan; 32(1):31-5. PubMed ID: 8495041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A canine nephropathy resembling minimal change nephrotic syndrome in man.
    Vilafranca M; Wohlsein P; Leopold-Temmler B; Trautwein G
    J Comp Pathol; 1993 Oct; 109(3):271-80. PubMed ID: 8300915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous improvement of minimal-change nephrotic syndrome and anemia with steroid therapy.
    Yabana M; Kihara M; Toya Y; Tamura K; Matsumoto K; Takagi N; Kamijo S; Ishii M; Umemura S
    Nephron; 1999 Jan; 81(1):84-8. PubMed ID: 9884426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoid nephrosis: an approach to the clinicopathologic analysis and dismemberment of idiopathic nephrotic syndrome with minimal glomerular changes.
    Jao W; Pollak VE; Norris SH; Lewy P; Pirani CL
    Medicine (Baltimore); 1973 Sep; 52(5):445-68. PubMed ID: 4725964
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipoid nephrosis appearing as acute oliguric renal failure.
    Hulter HN; Bonner EL
    Arch Intern Med; 1980 Mar; 140(3):403-5. PubMed ID: 7362359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal-change nephropathy associated with pancreatic carcinoma.
    Whelan TV; Hirszel P
    Arch Intern Med; 1988 Apr; 148(4):975-6. PubMed ID: 3355313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal change disease in pregnancy.
    Lo JO; Kerns E; Rueda J; Marshall NE
    J Matern Fetal Neonatal Med; 2014 Aug; 27(12):1282-4. PubMed ID: 24102437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotic syndrome with minimal glomerular lesions (lipoid nephrosis) in an adult diabetic patient.
    Brulles A; Caralps A; Vilardell M
    Arch Pathol Lab Med; 1977 May; 101(5):270. PubMed ID: 576799
    [No Abstract]   [Full Text] [Related]  

  • 40. Minimal-change nephropathy and malignant thymoma.
    Zinger C; Ben-Itzhak O; Szylman P; Green J; Nakhoul F
    Am J Nephrol; 1998; 18(1):61-3. PubMed ID: 9481441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.